European shares were unchanged on Friday, as losses in heavyweight healthcare shares were countered by an advance in oil and ...

The Sensex dropped 502 points on Friday to close at 81,758, while the Nifty slipped 143 points to end below the 25,000 mark ...

FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.

The Nikkei 225 has fallen 0.2%, while the Hang Seng index is 0.3% higher. The FTSE 100 index is seen opening about 21 points ...

The stock I'm talking about is CoreWeave (NASDAQ: CRWV), a company that is helping AI customers with something they need most right now, and that's access to high-performance computing.

Futures Movers Oil prices fall as OPEC+ ramps up production; U.S. stock futures decline as tariffs to go into effect Aug. 1 ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine segment. See why the stock is a Buy.

The US Dollar Index fell 10.8% in the first half of 2025 — its worst performance since 1973. The decline is driven in part by the "Sell America" trade amid economic and political concerns. A ...

GSK plc (NYSE: GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA approval for a 200 mg/mL autoinjector of Benlysta (belimumab) for the ...

Senator Maggie Hassan is investigating GSK's discontinuation of Flovent HFA, citing increased hospitalizations, higher drug costs, and lost Medicaid rebates.